Padding its savings account and then some, Nastech Pharmaceutical Co. Inc. raised about $57.4 million in gross proceeds through a public offering. (BioWorld Today)

Nastech Triples Cash With Public Sale Worth $57.4M

Dec. 10, 2004

By Aaron Lorenzo

No Comments

Padding its savings account and then some, Nastech Pharmaceutical Co. Inc. raised about $57.4 million in gross proceeds through a public offering. (BioWorld Today)

Liquidating Triad Sells P38 Program For Up To $66M

Dec. 9, 2004

By Aaron Lorenzo

No Comments

Liquidating Triad Sells P38 Program For Up To $66M

Dec. 9, 2004

By Aaron Lorenzo

No Comments

Endocyte Brings In $22.6M To Advance 'Smart Drugs'

Dec. 8, 2004

By Aaron Lorenzo

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Articles by Aaron Lorenzo

Leavitt Gets Nomination By Bush As New Head Of HHS

Leavitt Gets Nomination By Bush As New Head Of HHS

QuatRx Raises $31M In Third Round For Growing Pipeline

Hawaii Biotech Gets $15.5M In NIH Funding For Vaccines

Hawaii Biotech Gets $15.5M In NIH Funding For Vaccines

Nastech Triples Cash With Public Sale Worth $57.4M

Nastech Triples Cash With Public Sale Worth $57.4M

Liquidating Triad Sells P38 Program For Up To $66M

Liquidating Triad Sells P38 Program For Up To $66M

Endocyte Brings In $22.6M To Advance 'Smart Drugs'

Today's news in brief

Today's news in brief

Proteomics study explores how protein changes influence disease

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS